Document is current
Any future updates will be listed below
-
Authors
Pollyea, Daniel A. https://orcid.org/0000-0001-6519-4860
Tallman, Martin S.
de Botton, Stéphane
Kantarjian, Hagop M.
Collins, Robert https://orcid.org/0000-0003-0313-2394
Stein, Anthony S.
Frattini, Mark G.
Xu, Qiang
Tosolini, Alessandra
See, Wendy L.
MacBeth, Kyle J.
Agresta, Samuel V.
Attar, Eyal C.
DiNardo, Courtney D. https://orcid.org/0000-0001-9003-0390
Stein, Eytan M.
-
Funding
Funding for this research was provided by:
This study was funded by Celgene Corporation and Agios Pharmaceuticals, Inc.
- License Information
-
More Information
Article History
Received: 28 January 2019
Revised: 22 March 2019
Accepted: 25 March 2019
First Online: 9 April 2019
Compliance with ethical standards
:
: DAP receives research funding from Agios, AbbVie, and Pfizer, and serves on advisory boards for Celgene, Pfizer, Argenx, Agios, AbbVie, Agios, Celyad, and Gilead. MST received research funding from AROG, Cellerant, ADC Therapeutics, Celgene, Daiichi-Sankyo, and Orsenix, and participated in advisory boards for Orsenix, Biosight, and Daiichi-Sankyo. SdB received research funding from Agios Pharmaceuticals, Inc. and served on advisory boards for Agios Pharmaceuticals, Inc., Celgene, Pfizer, Novartis, Servier, Pierre Fabre, Bayer, Seagen, Carthagenetics, and Forma. HMK received research funding from Amgen, Ariad, Astex, BMS, Novartis, and Pfizer, and received honoraria from AbbVie, Amgen, Ariad, BMS, Immunogen, Orsinex, and Pfizer. RC received honoraria and received research funding from Agios Pharmaceuticals, Inc. <b>ASS</b> served on the speakers’ bureaus for Amgen and Celgene. MGF, QX, AT, and KJM are employed by and hold stock in Celgene. <b>WLS</b> is a contractor with Celgene. ECA and SVA are employed by and hold stock in Agios Pharmaceuticals, Inc. CDD is a consultant for Agios and Celgene, and served on the advisory board for Bayer, Karyopharm, MedImmune, and AbbVie. EMS has served on advisory boards for Astellas Pharma, Daiichi, Bayer, Novartis, Syros, Pfizer, PTC Therapeutics, AbbVie, Agios, and Celgene and has received research support from Agios, Celgene, Syros and Bayer.
